PARSEY MERDAD 1792150 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-10 | 2023-06-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 1294.0 | 4.02 | 0.01 | 78.12 | Direct | Common Stock | GILEAD SCIENCES, INC. | code F | 30887.0 | 1247.35 (GILD) |
| 2023-06-12 | 2023-06-10 | 2023-06-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | acq | 2779.0 | 8.64 | 0.02 | 0.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code M | 32181.0 | 1247.35 (GILD) |
| 2023-06-14 | 2023-06-13 | 2023-06-13 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 1485.0 | 4.81 | 0.01 | 76.9 | Direct | Common Stock | GILEAD SCIENCES, INC. | code S | 29402.0 | 1247.35 (GILD) |
| 2023-07-13 | 2023-07-13 | 3 | Parsey Merdad | DIRECTOR | holding | 8677.0 | 0 | 0.0 | Direct | Common Stock | SAGIMET BIOSCIENCES INC. | NA | 0.0 (SGMT) | |||
| 2023-07-20 | 2023-07-18 | 2023-07-18 | 4 | Parsey Merdad | DIRECTOR | dsp | 8677.0 | 100.0 | 0.0 | Direct | Common Stock | SAGIMET BIOSCIENCES INC. | code D | 0.0 | 0.0 (SGMT) | |
| 2023-07-20 | 2023-07-18 | 2023-07-18 | 4 | Parsey Merdad | DIRECTOR | acq | 12794.0 | 100.0 | 0.0 | Direct | Series A Common Stock | SAGIMET BIOSCIENCES INC. | code A C | 12794.0
|
0.0 (SGMT) | |
| 2023-09-11 | 2023-09-10 | 2023-09-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 1278.0 | 1.75 | 0.01 | 76.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code F | 71631.0 | 1246.01 (GILD) |
| 2023-09-11 | 2023-09-10 | 2023-09-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | acq | 2779.0 | 3.81 | 0.02 | 0.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code M | 72909.0 | 1246.01 (GILD) |
| 2023-09-13 | 2023-09-12 | 2023-09-12 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 1501.0 | 2.1 | 0.01 | 76.99 | Direct | Common Stock | GILEAD SCIENCES, INC. | code S | 70130.0 | 1246.01 (GILD) |
| 2023-12-11 | 2023-12-10 | 2023-12-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | acq | 2779.0 | 3.81 | 0.02 | 0.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code M | 72909.0 | 1246.04 (GILD) |
| 2023-12-11 | 2023-12-10 | 2023-12-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 1269.0 | 1.74 | 0.01 | 79.02 | Direct | Common Stock | GILEAD SCIENCES, INC. | code F | 71640.0 | 1246.04 (GILD) |
| 2024-02-02 | 2024-01-31 | 2024-01-31 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 23709.0 | 18.77 | 0.19 | 78.26 | Direct | Common Stock | GILEAD SCIENCES, INC. | code F | 102616.0 | 1246.04 (GILD) |
| 2024-02-02 | 2024-01-31 | 2024-01-31 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | acq | 76853.0 | 60.84 | 0.62 | 0.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code A | 126325.0
|
1246.04 (GILD) |
| 2024-02-29 | 2024-02-28 | 2024-02-28 to 2024-02-29 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 10230.0 | 9.94 | 0.08 | 72.82 | Direct | Common Stock | GILEAD SCIENCES, INC. | code S | 92706.0
|
1245.77 (GILD) |
| 2024-03-11 | 2024-03-10 | 2024-03-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | acq | 10401.0 | 10.09 | 0.08 | 0.0 | Direct | Common Stock | GILEAD SCIENCES, INC. | code M | 103107.0
|
1245.77 (GILD) |
| 2024-03-11 | 2024-03-10 | 2024-03-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 4803.0 | 4.66 | 0.04 | 75.12 | Direct | Common Stock | GILEAD SCIENCES, INC. | code F | 98304.0 | 1245.77 (GILD) |
| 2024-04-02 | 2024-04-01 | 2024-04-01 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 2000.0 | 2.03 | 0.02 | 72.96 | Direct | Common Stock | GILEAD SCIENCES, INC. | code S | 96304.0 | 1245.77 (GILD) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-10 | 2023-06-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 2779.0 | 5.64 | 0.02 | 0.0 | Direct | Restricted Stock Unit | GILEAD SCIENCES, INC. | code M | 46533.0 | 1247.35 (GILD) |
| 2023-07-13 | 2023-07-13 | 3 | Parsey Merdad | DIRECTOR | holding | 52634.0
|
0 | 7.66 | Direct | Stock Option (Right To Buy) | SAGIMET BIOSCIENCES INC. | NA | 0.0 (SGMT) | |||
| 2023-07-13 | 2023-07-13 | 3 | Parsey Merdad | DIRECTOR | holding | 4117.0 | 0 | 0.0 | Direct | Series E Preferred Stock | SAGIMET BIOSCIENCES INC. | NA | 0.0 (SGMT) | |||
| 2023-07-20 | 2023-07-18 | 2023-07-18 | 4 | Parsey Merdad | DIRECTOR | acq | 52634.0 | 100 | 7.66 | Direct | Stock Option (Right To Buy) | SAGIMET BIOSCIENCES INC. | code A | 23839.0
|
0.0 (SGMT) | |
| 2023-07-20 | 2023-07-18 | 2023-07-18 | 4 | Parsey Merdad | DIRECTOR | dsp | 52634.0 | 100.0 | 7.66 | Direct | Stock Option (Right To Buy) | SAGIMET BIOSCIENCES INC. | code D | 0.0
|
0.0 (SGMT) | |
| 2023-07-20 | 2023-07-18 | 2023-07-18 | 4 | Parsey Merdad | DIRECTOR | dsp | 327309.0 | 100.0 | 0.0 | Direct | Series E Preferred Stock | SAGIMET BIOSCIENCES INC. | code C | 0.0 | 0.0 (SGMT) | |
| 2023-09-11 | 2023-09-10 | 2023-09-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 2779.0 | 5.97 | 0.02 | 0.0 | Direct | Restricted Stock Unit | GILEAD SCIENCES, INC. | code M | 43754.0 | 1246.01 (GILD) |
| 2023-12-11 | 2023-12-10 | 2023-12-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 2779.0 | 6.35 | 0.02 | 0.0 | Direct | Restricted Stock Unit | GILEAD SCIENCES, INC. | code M | 40975.0 | 1246.04 (GILD) |
| 2024-03-11 | 2024-03-10 | 2024-03-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | acq | 89660.0 | 100.0 | 0.72 | 75.12 | Direct | Non Qualified Stock Option (Right To Buy) | GILEAD SCIENCES, INC. | code A | 89660.0 | 1245.77 (GILD) |
| 2024-03-11 | 2024-03-10 | 2024-03-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | acq | 17640.0 | 36.59 | 0.14 | 0.0 | Direct | Restricted Stock Unit | GILEAD SCIENCES, INC. | code A | 48214.0 | 1245.77 (GILD) |
| 2024-03-11 | 2024-03-10 | 2024-03-10 | 4 | Parsey Merdad | CHIEF MEDICAL OFFICER | dsp | 10401.0 | 25.38 | 0.08 | 0.0 | Direct | Restricted Stock Unit | GILEAD SCIENCES, INC. | code M | 30574.0
|
1245.77 (GILD) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)